We know that developments like the artificial pancrease can’t come quickly enough for people living with type 1 diabetes, and their families. That’s why we’re working really hard to make sure that the artificial pancreas becomes a reality as soon as possible. In January my colleagues at JDRF International (based in the USA) announced a partnership with Animas (a Johnson & Johnson company that manufactures pumps) to develop a first generation artificial pancreas.

The goal is to develop a system that can prevent the extremes of both hypoglycaemia and hyperglycaemia automatically – but will still need some input from the wearer, such as informing the system of meal times and periods of exercise.

This partnership is planned for four years and by the end we hope to reach the point where it will ready to go forward for approval by regulatory bodies like the US Food and Drug Administration (FDA) and the European Medicines Agency (EMEA), and from there to people with type 1.

I have had type 1 diabetes for 30 years, and I’m really excited about what this research could soon mean for me, and everyone else with type 1.